<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

4 min read

Biologics in Musculoskeletal Medicine

8/18/23 9:30 AM

Biologics Meeting Part 1SmartTRAK highlights key takeaways from the 2023 Biologic Association Meeting

At the 2023 Annual Meeting in monumental Washington DC, the Biologic Association and the American Society of Orthopaedic Surgeons (AAOS) teamed up with American Orthopaedic Society for Sports Medicine (AOSSM) to spotlight the growing interest in and latest advancements of biologics in musculoskeletal medicine. Taking center stage and garnering attention was the idea of “biological healing” and the use of biologics in various conditions and at different points of a continuum of care.

Not surprisingly, the Biological Association focused more on autologous therapies, cell culturing and the next generation of biologics, while the AOSSM meeting explored the current use and growing trends of traditional orthobiologics in orthopedic applications. This article, which is downloadable here, is part one in a two-part series highlighting key takeaways from the Biologic Association meeting, including:

  • Biologic Association Key Takeaways
  • Rules of Engagement: Regulations and Needed Standards
    • “Same Surgical Procedure Exception” Guidance
    •  Standards for Autologous Orthobiologics
    • Driving Better Patient Outcomes
  • Current Use of Autologous Therapies and Next Generation of Biologics
    • Current Practice
    • Next Generation of Biologics
  • Notable Investigative Technologies

Although several biologics seem promising to treat musculoskeletal conditions, there is still an uphill battle for widespread use. Current challenges include ...

To download "Biologics in Musculoskeletal Medicine," Part One of the series of articles by Kimberly French, SmartTRAK's GM, Orthobiologics and Regenerative Medicine, just click the button below. Look for Part Two in this series, which will cover key takeaways from AOSSM, highlighting the current use of Orthobiologics and growing trends, in the coming weeks.Download the Article

is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
Kim French
Written by Kim French

20+ years of progressive medical device and biologics marketing and sales experience in orthopedic biological implants, cellular technologies and biopharmaceuticals. Most recent experience includes President, Trilogy Consulting and Marketing and Sales Management roles at AlloSource and Terumo BCT.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles